FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:556-557 February 18, 1999 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Smith, T. L. Related Article by Sieradzki, K. PubMed Citation

"Tu quoque, fili?" means "You, my son, as well?" This was Julius Caesar's outcry when, surrounded by conspirators ready to stab him to death, he discovered among them Brutus, his adopted son. Caesar's outcry was one of surprise, but also one of recognition that Brutus's betrayal could have been predicted.

Vancomycin, now, as well? This was the semisurprised reaction of the microbiologic and medical community in 1997 — more than 50 years after the introduction of penicillin in the war against bacteria — to a well-documented report from Japan that vancomycin resistance was emerging as the latest setback . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Kollef, M. H. (2006). Time to get serious about infection prevention in the ICU.. Chest 130: 1293-1296 [Full Text]  
• Athanasopoulos, A. N., Economopoulou, M., Orlova, V. V., Sobke, A., Schneider, D., Weber, H., Augustin, H. G., Eming, S. A., Schubert, U., Linn, T., Nawroth, P. P., Hussain, M., Hammes, H.-P., Herrmann, M., Preissner, K. T., Chavakis, T. (2006). The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms. Blood 107: 2720-2727 [Abstract] [Full Text]  
• Cha, H. Y., Moon, D. C., Choi, C. H., Oh, J. Y., Jeong, Y. S., Lee, Y. C., Seol, S. Y., Cho, D. T., Chang, H.-H., Kim, S.-W., Lee, J. C. (2005). Prevalence of the ST239 Clone of Methicillin-Resistant Staphylococcus aureus and Differences in Antimicrobial Susceptibilities of ST239 and ST5 Clones Identified in a Korean Hospital. J. Clin. Microbiol. 43: 3610-3614 [Abstract] [Full Text]  
• King, A., Phillips, I., Kaniga, K. (2004). Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria. J Antimicrob Chemother 53: 797-803 [Abstract] [Full Text]  
• Faber, C., Stallmann, H. P., Lyaruu, D. M., de Blieck, J. M. A., Bervoets, Th. J. M., van Nieuw Amerongen, A., Wuisman, P. I. J. M. (2003). Release of antimicrobial peptide Dhvar-5 from polymethylmethacrylate beads. J Antimicrob Chemother 51: 1359-1364 [Abstract] [Full Text]  
• Gilbert, P., McBain, A. J. (2003). Potential Impact of Increased Use of Biocides in Consumer Products on Prevalence of Antibiotic Resistance. Clin. Microbiol. Rev. 16: 189-208 [Abstract] [Full Text]  
• Rasooly, A., Weisz, A. (2002). In Vitro Antibacterial Activities of Phloxine B and Other Halogenated Fluoresceins against Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46: 3650-3653 [Abstract] [Full Text]  
• Heym, B., Le Moal, M., Armand-Lefevre, L., Nicolas-Chanoine, M.-H. (2002). Multilocus sequence typing (MLST) shows that the 'Iberian' clone of methicillin-resistant Staphylococcusaureus has spread to France and acquired reduced susceptibility to teicoplanin. J Antimicrob Chemother 50: 323-329 [Abstract] [Full Text]  
• Eggimann, P., Pittet, D. (2001). Infection Control in the ICU. Chest 120: 2059-2093 [Abstract] [Full Text]  
• Osmon, D. R. (2001). Antimicrobial Resistance: Guidelines for the Practicing Orthopaedic Surgeon. JBJS 83: 1891-1901 [Full Text]  
• Fluit, A. C., Visser, M. R., Schmitz, F.-J. (2001). Molecular Detection of Antimicrobial Resistance. Clin. Microbiol. Rev. 14: 836-871 [Abstract] [Full Text]  
• Mulvey, M. R., Chui, L., Ismail, J., Louie, L., Murphy, C., Chang, N., Alfa, M., Canadian Committee for the Standardization of Mole, (2001). Development of a Canadian Standardized Protocol for Subtyping Methicillin-Resistant Staphylococcus aureus Using Pulsed-Field Gel Electrophoresis. J. Clin. Microbiol. 39: 3481-3485 [Abstract] [Full Text]  
• Kollef, M. H., Fraser, V. J. (2001). Antibiotic Resistance in the Intensive Care Unit. ANN INTERN MED 134: 298-314 [Abstract] [Full Text]  
• Vaudaux, P., Francois, P., Berger-Bachi, B., Lew, D. P. (2001). In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus. J Antimicrob Chemother 47: 163-170 [Abstract] [Full Text]  
• Philip, A. G. S., Mills, P. C. (2000). Use of C-Reactive Protein in Minimizing Antibiotic Exposure: Experience With Infants Initially Admitted to a Well-Baby Nursery. Pediatrics 106: 4e-4 [Abstract] [Full Text]  
• Burnie, J. P., Matthews, R. C., Carter, T., Beaulieu, E., Donohoe, M., Chapman, C., Williamson, P., Hodgetts, S. J. (2000). Identification of an Immunodominant ABC Transporter in Methicillin-Resistant Staphylococcus aureus Infections. Infect. Immun. 68: 3200-3209 [Abstract] [Full Text]  
• Bartlett, J. G. (1999). Update in Infectious Diseases. ANN INTERN MED 131: 273-280 [Full Text]  
• John, C. C., Smith, T. L., Pearson, M. L., Jarvis, W. R. (1999). Vancomycin Resistance in Staphylococcus aureus. NEJM 341: 207-208 [Full Text]  
• (1999). Danger: Vancomycin-Resistant Staphylococcus aureus. JWatch Infect. Diseases 1999: 1-1 [Full Text]  
• (1999). Vancomycin-Resistant S. aureus Has Arrived. Journal Watch Dermatology 1999: 11-11 [Full Text]  
• (1999). Vancomycin-Resistant *S. aureus* Has Arrived. JWatch General 1999: 2-2 [Full Text]